Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis
Suofu Ye(Peking University), Huihui Zeng(China Pharmaceutical University)
Cited by 32